{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":300,"width":600,"title":"\ud83e\uddec Detect, Decode, Decide: The Promise of Liquid Biopsy","description":"\ud83e\uddec Detect, Decode, Decide: The Promise of Liquid Biopsy Can a blood test tell us what cancer is doing before imaging can? \ud83e\ude78 Circulating tumor DNA (ctDNA) can identify actionable variants, track treatment response, detect resistance, and reveal molecular residual disease. In colorectal cancer, molecular relapse was detected ~8.7 months earlier than with imaging surveillance. \ud83d\udd2c But important questions remain: when should we test, how often, and should ctDNA positivity alone trigger treatment? ","author_name":"Dr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!","author_url":"http:\/\/www.MasterMedFacts.com","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/42475400\/height\/300\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"300\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/content\/205204350"}